• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The impact of statin use on disease-related symptoms in patients with chronic myeloproliferative neoplasms.

作者信息

Holik Hrvoje, Lucijanić Marko, Krečak Ivan

机构信息

Department of Internal Medicine, Dr. Josip Benčević General Hospital, Slavonski Brod, Croatia.

Faculty of Medicine, University of Osijek, Osijek, Croatia.

出版信息

Ann Hematol. 2024 May;103(5):1783-1785. doi: 10.1007/s00277-024-05693-0. Epub 2024 Mar 13.

DOI:10.1007/s00277-024-05693-0
PMID:38472363
Abstract
摘要

相似文献

1
The impact of statin use on disease-related symptoms in patients with chronic myeloproliferative neoplasms.他汀类药物使用对慢性骨髓增殖性肿瘤患者疾病相关症状的影响。
Ann Hematol. 2024 May;103(5):1783-1785. doi: 10.1007/s00277-024-05693-0. Epub 2024 Mar 13.
2
Statin exposure and thrombosis risk in patients with myeloproliferative neoplasms.骨髓增殖性肿瘤患者使用他汀类药物与血栓形成风险
Thromb Res. 2018 Jul;167:57-59. doi: 10.1016/j.thromres.2018.05.014. Epub 2018 May 16.
3
[Status and perspectives on chronic myeloproliferative neoplasm treatment].[慢性骨髓增殖性肿瘤治疗的现状与展望]
Ugeskr Laeger. 2015 May 4;177(19).
4
Pulmonary arterial hypertension and chronic myeloproliferative disorders.肺动脉高压与慢性骨髓增殖性疾病。
Am J Respir Crit Care Med. 2006 Sep 1;174(5):616. doi: 10.1164/ajrccm.174.5.616a.
5
Thiamine deficiency appears uncommon in patients with Myeloproliferative Neoplasms.硫胺素缺乏在骨髓增殖性肿瘤患者中似乎不常见。
Br J Haematol. 2017 Jul;178(2):338-340. doi: 10.1111/bjh.14128. Epub 2016 May 2.
6
Clinical experiences with ruxolitinib in symptomatic patients with myeloproliferative neoplasm with chronic kidney disease.芦可替尼用于有症状的慢性肾脏病骨髓增殖性肿瘤患者的临床经验。
Leuk Lymphoma. 2014 Jan;55(1):213-6. doi: 10.3109/10428194.2013.797086. Epub 2013 Jun 12.
7
Gangrene of the fingers secondary to myeloproliferative disease.骨髓增殖性疾病继发手指坏疽
Postgrad Med. 1991 Jul;90(1):115-8. doi: 10.1080/00325481.1991.11700984.
8
[The use of anagrelide to treat thrombocytosis in connection with the chronic myeloproliferative disease].[使用阿那格雷治疗与慢性骨髓增殖性疾病相关的血小板增多症]
Duodecim. 2006;122(4):453-7.
9
Statins in the treatment of polycythaemia vera and allied disorders: an antithrombotic and cytoreductive potential?他汀类药物治疗真性红细胞增多症及相关疾病：具有抗血栓形成和细胞减灭的潜力？
Leuk Res. 2006 Oct;30(10):1217-25. doi: 10.1016/j.leukres.2005.12.018. Epub 2006 Feb 17.
10
Hemarthrosis as the presenting manifestation of myeloproliferative disease.关节积血作为骨髓增殖性疾病的首发表现。
Arthritis Rheum. 1974 Nov-Dec;17(6):969-70. doi: 10.1002/art.1780170608.

引用本文的文献

1
Diabetes mellitus, metformin, and the risk of MPN.糖尿病、二甲双胍与骨髓增殖性肿瘤风险
Blood Adv. 2024 Nov 26;8(22):5929-5931. doi: 10.1182/bloodadvances.2024013772.

本文引用的文献

1
Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia.他汀类药物的使用与老年原发性血小板增多症和特发性骨髓纤维化患者的生存及血栓发生率。
Cancer Med. 2023 Sep;12(18):18889-18900. doi: 10.1002/cam4.6528. Epub 2023 Sep 13.
2
Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study.使用他汀类药物与骨髓增生性肿瘤风险：一项丹麦全国范围内的病例对照研究。
Blood Adv. 2023 Jul 25;7(14):3450-3457. doi: 10.1182/bloodadvances.2023009784.
3
The impact of statins on the intensity of phlebotomies in polycythemia vera.
他汀类药物对真性红细胞增多症放血治疗强度的影响。
Ann Hematol. 2020 Apr;99(4):911-912. doi: 10.1007/s00277-020-03950-6. Epub 2020 Feb 5.
4
Health related quality of life among myocardial infarction survivors in the United States: a propensity score matched analysis.美国心肌梗死幸存者的健康相关生活质量：倾向评分匹配分析。
Health Qual Life Outcomes. 2017 Dec 4;15(1):235. doi: 10.1186/s12955-017-0809-3.
5
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group.骨髓增殖性肿瘤患者的性别、疾病特征与症状负担之间的关联：MPN QOL国际工作组的分析
Haematologica. 2017 Jan;102(1):85-93. doi: 10.3324/haematol.2016.149559. Epub 2016 Aug 18.
6
Use of the Functional Assessment of Cancer Therapy--anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia.癌症治疗功能评估——用于骨髓增殖性肿瘤相关骨髓纤维化伴贫血患者的贫血评估。
Clin Ther. 2014 Apr 1;36(4):560-6. doi: 10.1016/j.clinthera.2014.02.016. Epub 2014 Mar 14.
7
JAK2-V617F-mediated signalling is dependent on lipid rafts and statins inhibit JAK2-V617F-dependent cell growth.JAK2-V617F 介导的信号转导依赖于脂筏，而他汀类药物抑制 JAK2-V617F 依赖性细胞生长。
Br J Haematol. 2013 Jan;160(2):177-87. doi: 10.1111/bjh.12103. Epub 2012 Nov 15.
8
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.骨髓增殖性肿瘤 (MPN) 症状评估表总症状评分：在 MPN 患者中前瞻性国际评估简化症状负担评分系统。
J Clin Oncol. 2012 Nov 20;30(33):4098-103. doi: 10.1200/JCO.2012.42.3863. Epub 2012 Oct 15.
9
Association of fatigue and psychological distress with quality of life in patients with a previous venous thromboembolic event.曾有静脉血栓栓塞事件的患者的疲劳和心理困扰与生活质量的关联。
Thromb Haemost. 2009 Dec;102(6):1219-26. doi: 10.1160/TH09-05-0316.
10
Statins in the treatment of polycythaemia vera and allied disorders: an antithrombotic and cytoreductive potential?他汀类药物治疗真性红细胞增多症及相关疾病：具有抗血栓形成和细胞减灭的潜力？
Leuk Res. 2006 Oct;30(10):1217-25. doi: 10.1016/j.leukres.2005.12.018. Epub 2006 Feb 17.